PT1095059E - Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao - Google Patents

Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao

Info

Publication number
PT1095059E
PT1095059E PT99933284T PT99933284T PT1095059E PT 1095059 E PT1095059 E PT 1095059E PT 99933284 T PT99933284 T PT 99933284T PT 99933284 T PT99933284 T PT 99933284T PT 1095059 E PT1095059 E PT 1095059E
Authority
PT
Portugal
Prior art keywords
chips
estafilococos
chemiaxia
utilization
protein inhibitor
Prior art date
Application number
PT99933284T
Other languages
English (en)
Inventor
Johannes Antonius Gerar Strijp
Cornelis Petrus Maria V Kessel
Original Assignee
Alligator Bioscience Ab Publ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alligator Bioscience Ab Publ filed Critical Alligator Bioscience Ab Publ
Publication of PT1095059E publication Critical patent/PT1095059E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rheumatology (AREA)
  • AIDS & HIV (AREA)
  • Pain & Pain Management (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
PT99933284T 1998-07-10 1999-07-12 Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao PT1095059E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL1009614 1998-07-10

Publications (1)

Publication Number Publication Date
PT1095059E true PT1095059E (pt) 2006-10-31

Family

ID=19767471

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99933284T PT1095059E (pt) 1998-07-10 1999-07-12 Proteina inibidora de quimiotaxia de estafilococos (chips) e sua utilizacao

Country Status (22)

Country Link
US (2) US20050143307A1 (pt)
EP (1) EP1095059B1 (pt)
JP (1) JP2002520336A (pt)
KR (1) KR20010053290A (pt)
CN (1) CN1309662A (pt)
AT (1) ATE328898T1 (pt)
AU (1) AU4935999A (pt)
BG (1) BG105120A (pt)
BR (1) BR9911944A (pt)
CA (1) CA2333898A1 (pt)
CY (1) CY1105343T1 (pt)
DE (1) DE69931784T2 (pt)
DK (1) DK1095059T3 (pt)
ES (1) ES2270609T3 (pt)
HU (1) HUP0102975A2 (pt)
IL (1) IL140768A0 (pt)
NO (1) NO20010140L (pt)
NZ (1) NZ509051A (pt)
PL (1) PL345452A1 (pt)
PT (1) PT1095059E (pt)
WO (1) WO2000002913A1 (pt)
ZA (1) ZA200100092B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2333898A1 (en) * 1998-07-10 2000-01-20 Jari Pharmaceuticals B.V. Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US20020086292A1 (en) 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
WO2003006048A1 (en) * 2001-07-11 2003-01-23 Jari Pharmaceuticals B.V. Combination of chips (chemotaxis inhibiting protein from staphylococcus aureus)-based compounds
DK1641926T3 (da) * 2003-07-08 2011-06-27 Umc Utrecht Holding Bv Terapeutisk anvendelse af LPI, en stafylokokal lectinstiinhibitor ved inflammatoriske sygdomme
EP1586583A3 (en) * 2004-04-16 2005-11-16 Alligator Bioscience AB (publ) Compounds that block C5a complement receptor and their use in therapy
US20090186111A1 (en) 2004-07-26 2009-07-23 Zeev Trainin Novel Bacteria and Pharmaceutically Active Products Obtained Therefrom
GB2432366B (en) * 2005-11-19 2007-11-21 Alligator Bioscience Ab A method for in vitro molecular evolution of protein function
GB0607798D0 (en) * 2006-04-20 2006-05-31 Alligator Bioscience Ab Novel polypeptides and use thereof
GB0905790D0 (en) 2009-04-03 2009-05-20 Alligator Bioscience Ab Novel polypeptides and use thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4772584A (en) * 1986-05-23 1988-09-20 Cleary Paul P Inhibitor of C5a-mediated chemotaxis
AU2509592A (en) * 1991-08-22 1993-03-16 Washington University Polynucleotide probes for salmonella
US5514555A (en) * 1993-03-12 1996-05-07 Center For Blood Research, Inc. Assays and therapeutic methods based on lymphocyte chemoattractants
US5514455A (en) * 1994-07-08 1996-05-07 Union Carbide Chemicals & Plastics Technology Corporation Film extruded from an in situ blend of ethylene copolymers
US5817476A (en) * 1995-06-07 1998-10-06 Genetics Institute, Inc. Polynucleotides encoding interleukin-1 receptor intracellular ligand proteins
US7153655B2 (en) * 1998-06-16 2006-12-26 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence
CA2333898A1 (en) * 1998-07-10 2000-01-20 Jari Pharmaceuticals B.V. Chemotaxis-inhibiting protein of staphylococcus (chips) and its use
JP3722194B2 (ja) * 1999-05-20 2005-11-30 セイコーエプソン株式会社 画像表示システム
EP1118663A1 (en) * 2000-01-07 2001-07-25 Universiteit Utrecht Nucleic acids encoding chemotaxis inhibitory polypeptides
US6958213B2 (en) * 2000-12-12 2005-10-25 Alligator Bioscience Ab Method for in vitro molecular evolution of protein function
US20020086292A1 (en) * 2000-12-22 2002-07-04 Shigeaki Harayama Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules
DK1504098T4 (da) * 2002-05-17 2011-05-23 Alligator Bioscience Ab Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion

Also Published As

Publication number Publication date
BR9911944A (pt) 2001-09-25
CA2333898A1 (en) 2000-01-20
ZA200100092B (en) 2001-07-23
WO2000002913A1 (en) 2000-01-20
ES2270609T3 (es) 2007-04-01
JP2002520336A (ja) 2002-07-09
WO2000002913B1 (en) 2000-03-30
US20080242605A1 (en) 2008-10-02
DE69931784D1 (de) 2006-07-20
ATE328898T1 (de) 2006-06-15
NZ509051A (en) 2003-01-31
EP1095059A1 (en) 2001-05-02
CN1309662A (zh) 2001-08-22
NO20010140D0 (no) 2001-01-09
IL140768A0 (en) 2002-02-10
DK1095059T3 (da) 2006-10-02
HUP0102975A2 (hu) 2001-11-28
CY1105343T1 (el) 2010-03-03
AU4935999A (en) 2000-02-01
NO20010140L (no) 2001-03-01
EP1095059B1 (en) 2006-06-07
PL345452A1 (en) 2001-12-17
BG105120A (en) 2001-11-30
DE69931784T2 (de) 2007-06-14
KR20010053290A (ko) 2001-06-25
US20050143307A1 (en) 2005-06-30

Similar Documents

Publication Publication Date Title
EA200301115A1 (ru) Кристаллические формы азитромицина
BR0014470A (pt) Inibidores de fab i
PT1109812E (pt) Pirrolobenzodiazepinas
NO20051082L (no) Antimikrobielle kinoloner, deres sammensetninger og anvendelser
ATE267830T1 (de) Als cox-hemmer verwendbare sulfonylphenylpyrazol- verbindungen
ATE233274T1 (de) Oxyiminopregnancarbolactone
TR200003170T2 (tr) MRS inhibitörleri ve bakterisid olarak kullanılan quinolone'lar
CY1105343T1 (el) Σταφυλοκοκκικη πρωτεϊνη αναστολης του χημειοτακτισμου (chips) και η χρηση αυτης
PT1307455E (pt) Inibidores de adesao celular mediada por (alfa)l (beta)2
ATE433963T1 (de) Fab-i inhibitoren
ES2171723T3 (es) 3,4-diaril-2-hidroxi-2,5-dihidrofuranos como profarmacos de inhibidores de cox-2.
ATE335499T1 (de) Zusammensetzungen zur behandlung von staphylococcus aureus infektionen
DE60043868D1 (de) Abgeschwächte Mikroorganismen für die Behandlung von Infektionen
SE0003476D0 (sv) Compounds
ATE335739T1 (de) Cak inhibitoren und deren verwendungen
SE9903290D0 (sv) Novel compounds
DK1558580T3 (da) N-sulfonyl-4-methylenamino-3-hydroxy-2-pyridoner
PT1244614E (pt) Inibidores de triptase
PT1104419E (pt) Derivados de azabicicloheptano substituidos no azoto sua preparacao e utilizacao
DE60003074D1 (de) Fusidinsäure-derivate
TR200003084T2 (tr) Paroxetine askorbat
PT1358182E (pt) Derivados de diazocinas e sua utilizacao como inibidores de triptase
SE0001631D0 (sv) New use
SE0002045D0 (sv) New use
DE60324466D1 (de) Zusammensetzungfür die behandlung von mycobakterieninfektionen